Divi's Laboratories Limited

NSE: DIVISLABHealthcareLot size: 100

Divi's Laboratories Limited FII & DII Activity

FII Net (₹ Cr)
+871.83Buy 16,834.53Sell 15,962.7
DII Net (₹ Cr)
+643.35Buy 17,240.9Sell 16,597.55
FII F&O Net (contracts)
+643395Index + stock futures

5-Day Flow Trend

DateFII Net (₹ Cr)DII Net (₹ Cr)
2026-10-28+871.83+643.35
2026-10-27−1462.49+2609.57
2026-10-26−1462.49+2609.57
2026-10-23+887.65+3235.36
2026-10-22−3458.70+2891.32
AI AnalysisGenerated daily after market close · AI-powered

Today's Institutional Flow

Dividends Laboratories Limited sees a net inflow of ₹871.83 crore from foreign institutional investors (FII) in cash transactions today, while domestic institutional investors (DII) add a further ₹643.35 crore. The combined cash injection of roughly ₹1.515 trillion underscores a bullish sentiment from both foreign and domestic money‑flows. No block or bulk trades are reported for the stock, indicating that the accumulation is occurring through regular market participation rather than large discrete blocks.

Trend vs 5‑Day Average

The day’s FII cash flow of +₹871.83 crore stands in stark contrast to the five‑day average net outflow of ₹‑894.74 crore, highlighting a pronounced reversal toward buying pressure. Conversely, DII activity remains comfortably above its five‑day average of +₹2,592.03 crore, reinforcing the sustained domestic enthusiasm that has persisted over the past week.

F&O Positioning Data

Foreign investors hold a net long position of ₹643,395 crore in F&O contracts on Dividends Laboratories, reflecting significant speculative or hedging interest. The index futures ratio of 1.2 indicates that FII long positions outweigh short positions by 20 percent, suggesting a mildly bullish bias in the broader market outlook.

Healthcare Sector Flow

Across the healthcare sector, recent weeks have witnessed a steady accumulation by both FIIs and DIIs, with foreign money turning net buyers after a period of modest outflows, while domestic institutions continue to add to their long positions.

Market-wide FII/DII data — same for all F&O stocks. Date: 2026-10-28

Frequently Asked Questions

What is FII net buying/selling in Divi's Laboratories Limited today?
FII (Foreign Institutional Investor) net flow in the Indian cash market today is ₹871.83 Cr (net buying) as of 2026-10-28. This market-wide figure applies to all F&O stocks including Divi's Laboratories Limited.
What is DII activity in Divi's Laboratories Limited today?
DII (Domestic Institutional Investors — mutual funds, insurance companies) net flow is ₹643.35 Cr (net buying) today. DIIs often act as a counterbalancing force to FII flows — on days when FIIs sell, DIIs typically provide support.
What is FII F&O net for Divi's Laboratories Limited today?
FII net F&O position (index + stock futures combined) is +6,43,395 contracts as of the latest participant OI data. A positive number means FIIs are net long in futures; negative means net short.
Were there any block deals in Divi's Laboratories Limited?
Block deal data for Divi's Laboratories Limited is tracked daily from NSE's block deal window. On days with activity, the deal value in ₹ Crore is shown on this page.
How does FII/DII data affect Divi's Laboratories Limited stock price?
FII and DII flows are market-wide data — all F&O stocks including Divi's Laboratories Limited are influenced. When FIIs buy heavily (positive net), it typically supports the broader market. When FII F&O net is strongly positive (long futures), it signals institutional conviction in an uptrend. Combined with Divi's Laboratories Limited's individual OI buildup type, this provides a directional framework.